Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

New evolutions for the neoadjuvant and adjuvant treatment of oesophageal cancer

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 05.07.17
Views: 768

Prof Florian Lordick - University Cancer Center Leipzig, Leipzig, Germany

Prof Lordick talks with ecancer at ESMO GI 2017 about news and new evolutions for neoadjuvant and adjuvant treatment of oesophageal cancer. He discusses the new ESMO guidelines for oesophageal cancer and talks about the need to separate recommendations for oesophageal cancer and adenocarcinoma because of the different biology of the diseases.

Related videos

follow us

ONJ e-learning

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

Cancer Intelligence